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Abstract: In this paper, we show the effect of crambescidin-816, -800, and -830 on 
Saccharomyces cerevisiae viability. We determined that, of the three molecules tested, 
crambescidin-816 was the most potent. Based on this result, we continued by determining 
the effect of crambescidin-816 on the cell cycle of this yeast. The compound induced cell 
cycle arrest in G2/M followed by an increase in cell DNA content and size. When the type 
of cell death was analyzed, we observed that crambescidin-816 induced apoptosis. The 
antifungal effect indicates that crambescidins, and mostly crambescidin-816, could serve as 
a lead compound to fight fungal infections. 
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1. Introduction 
Marine sponges are among the most important producers of secondary metabolites with 
antimicrobial effect. After centuries of evolutionary pressure, these sessile marine filter feeders have 
developed a very efficient chemical arsenal against virus, bacteria, and eukaryotic organisms. More 
than 200 new metabolites from this group of animals are reported each year and more than  
5300 different secondary metabolites are known from sponges [1,2]. Meanwhile, in the last decade, 
many compounds with antifungal activity have been isolated from sponges (for comprehensive 
reviews see [3–6]) indicating that this group of organisms is a valuable source of this type of 
compounds. The sponge Crambe crambe commonly found in the rocky costs of the Mediterranean sea, 
is capable of inducing necrosis of other sponge tissues when they are kept in contact [7], and was 
initially reported to produce potent antibacterial and antifungal compounds [8]. Additionally, 
metabolites of this highly toxic sponge have proven to have antifouling activity against microfoulers 
and invertebrate larvae [9]. Two families of guanidine alkaloids have been isolated from Crambe 
crambe, namely crambescidins and crambescins. Some of these have been shown to have mid 
nanomolar cytotoxicities against human tumor derived cell lines [10]. Crambescidin-800 (C800) 
induces differentiation of K562 leukemia cells leading to cell cycle arrest in S-phase [11]. C800 was 
initially identified as a promising antiviral and antifungal compound [10], and later purified from 
Monanchora unguifera in the search of antifungal leads, after a high-throughput screening with the 
aim of discovering biologically active small molecules, using Saccharomyces cerevisiae as model 
organism. This compound presented an IC20 in liquid culture of 0.83 µM, similar to that of the most 
active selected compounds from the NCI diversity set (collection of 2000 synthetic small molecules 
selected from the full NCI screening collection) [12]. Another crambescidin isolated from Crambe 
crambe is crambescidin-816 (C816). This compound has been shown to exert a Ca
2+
 antagonistic 
activity with higher potency than nifedipine [13,14]. It is also active against human colon carcinoma 
cells [13]. 
Due to the problems associated with current antifungal drugs, and the increasing number of 
invasive fungal infections in immunocompromised patients, a new generation of antifungal drugs is 
urgently needed. Since crambescidin-800 has shown promising antifungal activity, and based on the 
data available for crambescidin-816 showing that it has a higher activity than crambescidin-800 in 
eukaryotic cells, we tested the antifungal effect of crambescidin-816 in comparison with  
crambescidin-800 and another of its family members -830 (C830, Figure 1) in S. cerevisiae, which is 
recognized to be a good model for antifungal drug development [15]. We herein show that 
crambescidin-816 reduces cell viability in S. cerevisiae inducing an increment in cell size and DNA 
content, and apoptosis. The potency of this compound is 10 times higher than that of crambescidin-800 
and 4 times higher than that of crambescidin-830. 
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Figure 1. Chemical structures of crambescidin-816, -800, and -830. 
 
2. Results and Discussion 
2.1. C816 Is More Potent on S. cerevisiae than C800 and C830, and Has a Fungicidal Effect 
We compared the effect of C816, C800 and C830 on S. cerevisiae cell growth in order to determine 
their relative potencies. We observed that the most potent molecule was C816 followed by C830 and 
C800 with MIC50 (the antimicrobial concentration the inhibits 50% of the growth) at 24 h of  
0.557 (95% confidence interval = 0.5116 to 0.608), 1.650 (95% confidence interval = 1.374 to 2.011), 
and 4.316 (95% confidence interval = 4.210 to 4.427) µM respectively. C816 was almost 10 times 
more potent than C800 (Figure 2). 
Figure 2. Determination of the MIC50 for C800, C816 and C830 in S. cerevisiae after 24 h. 
The optical density determined for each treatment was plotted against the concentrations 
tested, expressed in molarity. The mean (n = 4) ± SD for each treatment is shown. 
 
As previously stated in the introduction, C800 has been previously identified as a potent antifungal 
agent with an IC20 of 0.83 µM [12]. At the concentration reported by these authors we observed no 
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effect on S. cerevisiae cell growth after 24 h. This could be due to the different approaches used for the 
determination of the effect of the tested compound on cell growth. As shown below, C816 induces a 
delay of cell growth after short time periods, which is not observed after 24 h. This could explain why 
the cited authors observed an inhibition of 20% of cell growth at a concentration of 0.83 µM while we 
determined a minimum inhibitory concentration of 4.316 µM after 24 h. An increased lag phase, 
induced by C800 could produce an IC20 (defined as the concentration in which the doubling time of the 
DMSO control divided by the doubling time with compound was equal to 0.8) lower than that 
observed after incubation for longer time periods. Also, a difference resulting as a consequence of 
using different strains of S. cerevisiae cannot be ruled out. We continued our study with the most 
potent compound, C816. 
To investigate the effect of C816 on S. cerevisiae growth, cultures of this organism were exposed to 
C816 up to 24 h, and cell growth was monitored measuring the OD of the cultures. We determined that 
the tested compound inhibited S. cerevisiae growth in a dose dependent manner (Figure 3). At the two 
highest concentrations tested no cell growth was observed up to 24 h. Lower concentrations (100 and 
300 nM) were capable to delay the growth of the culture after the first 15 h but finally the cultures 
reached the same density as control cells after 24 h. 
Figure 3. Growth inhibition of S. cerevisiae cultures treated with various doses of C816 
(100–1000 nM). No growth was observed in cultures treated with 700 and 1000 nM C816. 
The mean (n = 4) ± SD for each treatment is shown. 
 
We then assayed if C816 was a fungistatic or if it acted as a fungicide in S. cerevisiae. Cells incubated 
with 300, 700 and 1000 nM C816 for 3 or 6 h and then cultured in toxin free medium up to 24 h (see 
Experimental Section for a detailed explanation of culture conditions) presented a reduced viability at 
both times tested (Figure 4). Cells exposed to C816 for 6 h showed a reduced growth when compared 
to those treated with the compound for 3 h. In both cases, a dose dependent response was observed. 
The results show that C816 is cytotoxic for S. cerevisiae. After 24 h the cultures treated with the 
highest concentration tested, reached approximately half of the growth seen in controls. These results 
indicate that C816 acts as a fungicidal and not as a fungistatic. 
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Figure 4. Determination of the fungicidal effects of C816 on S cerevisiae. Cultures were 
treated with 500, 700 and 1000 nM C816 for 3 or 6 h. After toxin treatment cells were 
washed and kept in culture for another 24 h. Culture growth was determined measuring the 
OD at 600 nm. Significant differences respect to control * p < 0.01, n = 4. 
 
2.2. C816 Induces Cell Cycle Arrest and an Increase in S. cerevisiae DNA Content 
To assay if C816 affected the cell cycle of S. cerevisiae, cultures of these cells were treated with 
C816 and then studied by imaging flow cytometry. Examples of histograms obtained are shown  
in Figure 5a. We observed what initially appeared as cell cycle arrest in G2/M in the first 2 h of culture 
as determined by the increased population of cells in this phase of the cell cycle for cultures treated 
with 700 and 1000 nM C816. Longer incubation periods indicated that C816 induced the appearance 
of cells with a broad range of DNA content. We observed a population of cells with ploidy higher than 
4C, which was higher after 6 h of incubation with 700 and 1000 nM C816 and after 10 h of incubation 
with 300 nM C816 (Figure 5a). No difference was observed after 24 h. At this time point, an increase 
in cells with a DNA content below of 1C was detected, which is indicative of apoptosis (Figure 5b). 
Cells with up to 32C were detected at the two highest concentrations tested. 
The increased DNA content in C816 treated cells could be due to increased mitochondrial DNA 
content [16]. A similar effect has been observed in S. cerevisiae after treatment with the  
microtubule-depolymerizing drug nocodazole, a compound that induced mitotic cell death with 
apoptotic-like features [17]. On the other hand, cell death could be a consequence of an abnormal 
morphogenetic response in the presence of C816 making the cells commit new rounds of DNA 
replication in the absence of cytokinesis, or cell cycle arrest in anaphase. It has been previously shown 
that S. cerevisiae can replicate their DNA in the absence of cytokinesis [18], as consequence of septa 
mislocalization [19,20]. This raises the possibility that crambescidins could interfere with cell wall 
synthesis or organization. The cortical actin cytoskeleton is essential for the development of a functional 
cell wall and is localized at particular areas at different stages of the cell cycle [21,22]. We have 
observed that C816 interferes with tumor cell actin cytoskeleton [23], so an effect of this compound on 
yeast cytoskeleton is also a possibility. Further research is needed to confirm these assumptions. 
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2.3. C816 Induces an Increase in Cell Size 
The images obtained after imaging flow cytometry showed, besides an increase in DNA content, an 
increment in cell size that appeared early after treatment (Figure 6a). This was also observed after 
inspection of the cultures by bright field microscopy (Figure 6b). 
An increase of cell size is expected since the higher DNA content requires an augmented cell size to 
accommodate the genetic material. 
Figure 5. C816 induces an increase in the DNA content in S. cerevisiae. (a) Histograms 
obtained after flow cytometry of S. cerevisiae treated with C816 for 2, 4, 6, 10 and 24 h. 
Marked with a rectangle are the cells with 1C, 2C cell cycle distribution. (b) Analysis of 
cell population distributions after the different treatments performed. Each treatment was 
assayed in triplicate, and two experiments were performed. The mean (n = 3) ± SD for 
each treatment is shown. 
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Figure 5. Cont.  
 
Figure 6. C816 induces an increment of the cell size in S. cerevisiae. (a) Representative 
images of cells in the different populations of the cell cycle after treatment with C816 
obtained by imaging flow cytometry. Control samples showed cell with 1 and 2C, while 
C816 treatment induced the appearance of cells with 4, 8, 16 and 32C. (b) Bright field 
microscopy of control and C816 treated S. cerevisiae. An increase in cell size can be 
observed in treated cells, especially in cells treated with 700 and 1000 nM C816.  
Scale bar = 10 µm. 
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2.4. C816 Induces Apoptosis in S. cerevisiae 
In cdc13-1 cells (S. cerevisiae mutant for CDC13, a telomere binding protein that prevent 
degradation of telomeres) grown at restrictive temperature, it has been shown that increased cell size 
can result in cell lysis. These cells maintain high viability for several hours during which time continue 
to grow increasing two- to three-fold in diameter. When such cells reach a critical size, they lyse [24]. 
To assay if the increment in cell size induced by C816 could produce cell lysis, exponentially growing 
cultures of S. cerevisiae were treated with 300, 700, and 1000 nM C816. After 10 h the cells were 
washed and then incubated in the presence of PI to determine the integrity of the plasma membrane. 
Treated cells did not show an increased presence of stained cells when compared to controls 
(Supplementary Figure S1). 
After discarding the existence of necrosis and, since yeast has been shown to undergo apoptosis by 
numerous types of insults [25], we analyzed if C816 induced apoptosis. As shown in Figure 5b, an 
increase in the sub-G0/G1 cell population was observed after 24 h of C816 treatment (see 
Supplementary Figure S2 for scaled up histograms that better show this population). To better assay if 
C816 induced apoptosis in S. cerevisiae we performed Annexin V and PI staining experiments. 
Annexin V has specific affinity to phosphatidylserine (PS). Soon after apoptosis is induced, PS 
translocates from the inner to the outer leaflet of the plasma membrane [26]. After translocation PS can 
readily bind Annexin V, which coupled to FITC, was detected by flow cytometry and fluorescence 
microscopy. PI was also used for apoptosis determination. It binds to DNA and is impermeant to live 
and apoptotic cells, but stains necrotic cells. Annexin V staining showed that C816 induces apoptosis 
in S. cerevisiae. As determined by fluorescence microscopy, after 10 h there was an important increase 
of Annexin V positive cells without PI staining, indicative of cells in early apoptosis, while after 24 h 
we observed Annexin V staining and the appearance of PI positive cells indicative of cells in late 
apoptosis (secondary necrotic) (Figure 7a). When cells were analyzed for Annexin V and PI staining 
by flow cytometry, we observed mainly a dose dependent increase in Annexin V stained cells after 
10 h of C816 treatment (Figure 7b,c). At this time, a dose dependent reduction in cell survival was 
detected (Figure 7d). Supplementary Figure S3 shows representative images for healthy, Annexin V 
stained cells, and Annexin V-PI stained cells. As previously stated, apoptotic-like cell death has been 
previously described in S. cerevisiae after treatment with nocodazole [17]. Also, several other 
antineoplastic and antifungal drugs, some of which are actually used in the clinic like Amphotericin B, 
have already been demonstrated to induce apoptosis in yeast [27]. 
After apoptosis determination by fluorescence microscopy and flow cytometry, similar results were 
obtained showing an increase in the apoptotic population after 10 h. After a longer incubation period, 
PI staining was observed indicative of secondary necrosis. In unicellular eukaryotes, the apoptosis 
outcome is secondary necrosis were cytoplasmic membrane permeabilization occurs and PI staining is 
detected. This type of necrosis was named as being secondary to distinguish this mode of cell 
elimination from cellular necrosis occurring without apoptosis, termed primary necrosis [28]. 
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Figure 7. (a) Annexin V and PI staining of S. cerevisiae after C816 treatment for 10 and 
24 h. Green: Annexin V. Red: PI. After 10 h only Annexin V staining is observed. PI 
staining is observed but after 24 h of treatment. Scale bar = 10 µm (b) Apoptosis 
determination by flow cytometry in S. cerevisiae after C816 treatment for 10 h. The toxin 
induced a dose dependent increase in Annexin V stained cells. Representative results are 
shown. (c) Quantification of Annexin V positive cells detected by flow cytometry.  
* Significant differences respect to control p < 0.01, n = 3. (d) Survival plating assay for 
cells treated as those analyzed by flow cytometry. After C816 treatment for 10 h, cells 
were serially diluted, plated and incubated at 30 °C. Colonies were counted after 48 h.  
* Significant differences respect to control p < 0.01, n = 3, ** significant differences 
respect to control p < 0.05, n = 3. 
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2.5. C816 Disrupts the Mitochondrial Membrane Potential (ΔΨm) in S. cerevisiae 
Mitochondrial permeability transition is a critical step in the cellular apoptotic pathway [29], it 
precedes phosphatidylserine flip-flop and coincides with caspase activation [30]. This process 
produces the disruption of the electrochemical gradient in the mitochondria by pore formation [31]. 
The basic molecular machinery of programmed cell death has been shown to be phylogenetically 
conserved in yeast as well as animals [25]. Several compounds, like acetic acid [32,33], H2O2 [34], and 
aspirin [35] have been shown to induce apoptosis, involving mitochondrial dysfunction, in yeast. To 
determine if C816 affected the mitochondrial ΔΨm, we treated S. cerevisiae with this compound for  
6 h, the incubation period at which the highest ploidy was detected after exposure to 700 and 1000 nM 
C816, and then analyzed the mitochondrial function using the JC-1. This dye, in the presence of high 
mitochondrial ΔΨm, forms aggregates with orange fluorescence. In cells with damaged mitochondria 
JC-1 remains in the monomeric form, which shows only green fluorescence [36]. After analysis by 
imaging flow cytometry the results showed that C816 reduced the mitochondrial ΔΨm at the two 
highest concentrations tested (Figure 8a). Even though 300 nM C816 appeared to decrease the 
mitochondrial ΔΨm, the difference was not statistically significant. Examples of cells with healthy and 
damaged mitochondria detected after imaging flow cytometry are shown in Figure 8b. 
Figure 8. (a) Quantification of the relative mitochondrial fluorescence (RMF) in C816 
treated S. cerevisiae. * Significant differences respect to control p < 0.01, n = 3. (b) Images 
obtained by imaging flow cytometry of cells with functional and damaged mitochondria. 
SS: Side scatter, Bf: Bright field, GF: Green fluorescence, OF: Orange fluorescence, and 
GOBfC: Composite of the bright field, green and red fluorescence. 
 
Increase in DNA content and mitochondrial depolarization with the consequent apoptosis could be 
related since hyperploid cells, which show an increased size, also show loss of mitochondrial 
membrane potential. We are currently trying to determine if this is the case. 
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Saccharomyces cerevisiae, which is closely related to fungi harmful for humans [37], has been 
shown to be a good model system for studying the properties of antifungal compounds. Besides this, 
yeast has been used to study antifungals against more evolutionary distant fungi (e.g., filamentous fungi). 
The majority of the currently used antifungal drugs are active against S. cerevisiae making it a suitable 
model for both drug development and the elucidation of the mechanisms underlying drug’s action [15]. 
In this work we show that C816 is a fungicidal and induces apoptosis in S. cerevisiae making it a 
potential candidate to be used as an antifungal or as a lead molecule for antifungal development. 
3. Experimental Section 
3.1. Molecules Tested 
Crambescidin-816, -800 and -830 (Figure 1) were purified from the sponge Crambe crambe as 
described in [38]. The compounds were dissolved in DMSO and were 95% pure (HPLC-MS). The 
final DMSO concentration for cell treatment was always lower than 0.2%. Control cultures were 
treated with the highest DMSO concentration used in each experiment, to rule out any solvent 
interference in the results observed. 
3.2. Cell Strain and Culture 
The Saccharomyces cerevisiae strain NCPF3191 (ECACC) was used for all the experiments 
reported in this work. Cells were grown in YPD (20 g/L bacteriological peptone, 10 g/L yeast extract, 
20 g/L glucose; SIGMA) at 30 °C with agitation. For culture maintenance, cells grown on YPD-agar 
(20 g/L bacteriological peptone, 10 g/L yeast extract, 20 g/L glucose, 15 g/L agar; SIGMA) were 
regularly re-plated. 
3.3. Cell Growth Inhibition Determination 
Growth inhibition of S. cerevisiae in the presence of crambescidins was determined by a 
spectrophotometric bioassay to determine the MIC50 (the antimicrobial concentration the inhibits  
50% of the growth) based on the change of absorbance at 600 nm of yeast cultures in 48 well plates. 
An overnight culture was diluted to a concentration of 3 × 10
7
 cells per mL as determined with a 
hematocymeter. After dilution, 3 × 10
5
 cells per well were seeded in 48 well plates and then treated 
with Crambescidin-816, -800 of -830. The plates were incubated at 30 °C in a shaking incubator for  
24 h. Absorbance was determined prior to treatment and up to 24 h of incubation with shacking at  
30 °C, in a SYNERGY 4 spectrophometer (BIO-TEK). 
3.4. Determination of Fungicidal Effect 
The fungicidal effect of C816 was determined as previously described [39] with modifications. In 
brief, overnight cultures of S. cerevisiae were diluted to 1 × 10
6
 cell/mL in YPD media and incubated 
in 48 well plates in the presence of C816 or vehicle for 3 or 6 h at 30 °C with agitation. After 
incubation with the compound, cells were centrifuged and washed twice with YPD. Cells were 
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resuspended in YPD media and cultured in 48 well plates up to 24 h at 30 °C with agitation. The 
optical density at 600 nm was determined as a measure of cell growth after the 24 h incubation elapsed. 
To determine cell survival after C816 treatment we also performed serial dilutions of control and 
treated cultures and plated the cells on YPD-agar plates. Cells were incubated for 48 h at 30 °C and 
colonies were counted. Each treatment was assayed in triplicate to determine the percentage of cell 
survival in C816 treated cultures respect to controls. 
3.5. Cell Cycle Assay by Flow Cytometry 
An overnight culture of S. cerevisiae was diluted to 5 × 10
6
 cell per milliliter and incubated in  
48 well plates in the presence of crambescidin-816 for 2, 4, 6, 10 and 24 h. After each incubation, cells 
were washed twice with PBS and then fixed with 70% ice cold ethanol for 1h at 4 °C. Fixed cells were 
washed twice with PBS and then incubated with 10 µg/mL propidium iodide (PI, SIGMA) and  
0.1 mg/mL RNAse (SIGMA) dissolved in PBS for 1 h. Stained cells were sonicated for 1 min and 
10,000 events for each sample were acquired with an AMNIS imaging flow cytometer using the 
AMNIS INSPIRE™ software. Data analysis was performed with the AMNIS IDEAS™ software. The 
experiments were performed by triplicate. 
3.6. Determination of Apoptosis by Annexin V and Propidium Iodide (PI) Staining 
To perform the assay, an overnight culture of S. cerevisiae was diluted to 5 × 10
6
 cell per milliliter 
and incubated in 48 well plates in the presence of crambescidin-816 for 10 or 24 h. After treatment, 
Annexin V staining was performed as previously described [40]. In brief, cells were washed with 
sorbitol wash buffer (1.2 M sorbitol, 0.5 mM MgCl2, 35 mM potassium phosphate, pH 6.8) and then 
digested with 20 U/mL of lyticase dissolved in sorbitol wash buffer for 1 h at 28 °C. Cells were then 
washed with sorbitol binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4). The 
cells were resuspended in 40 µL of sorbitol binding buffer and two microliters of Annexin V 
(IMMUNOSTEP) and 1 µL of 500 µg/mL PI were added. Cells were stained for 20 min at room 
temperature in the dark and then washed in sorbitol binding buffer. Finally the cells were resuspended 
in sorbitol binding buffer and observed under a fluorescence microscope, or analyzed by flow cytometry. 
3.7. Determination of Mitochondrial Transmembrane Potential (ΔΨm) 
Changes in mitochondrial ΔΨm were determined as previously described [41]. Control and C816 
treated cells were washed with PBS and then resuspended in PBS with 2 µg/mL JC-1  
(5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide) and 2% glucose. Cells 
were stained for 30 min at 37 °C in the dark. After staining, cells were washed with PBS, resuspended 
in PBS supplemented with 2% glucose and analyzed by imaging flow cytometry. To perform 
compensation and as a positive control for mitochondrial uncoupling, FCCP (carbonyl cyanide  
4-(trifluoromethoxy) phenylhydrazone) treated S. cerevisiae were used. This compound is a 
protonophore that uncouples oxidation from phosphorylation in mitochondria. FCCP, 10 µM final 
concentration, was added at the same time as JC-1. Ten thousand events were acquired of each sample 
detecting fluorescence in the green and orange channels. The relative mitochondrial fluorescence 
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(RMF) was defined as the ratio aggregated JC-1 (orange):Monomeric JC-1 (green), which reflects the 
changes in ΔΨm per unit of mitochondrial mass. 
3.8. Statistics 
The results were analyzed using the SIGMAPLOT
®
 software. One way ANOVA was used for 
comparison of differences among groups. The Holm-Sidak multiple-range test was used for 
comparisons of differences between groups. A p < 0.05 was considered significant. 
4. Conclusion 
In conclusion, we show that C816 has a fungicidal effect in yeast and is more potent than C830 and 
the previously postulated lead for antifungal development C800. S. cerevisiae in the presence of C816 
increases its size as a consequence of higher DNA content. The most potent compound tested induced 
mitochondrial dysfunction and apoptosis in yeast as determined by the appearance of a sub-G0/G1 
population, phosphatidylserine translocation and collapse of the mitochondrial ΔΨm in treated cells. 
This work indicates that C816 could be a good lead for antifungal development. 
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